Disclosures for "Value of FVC and its Rate of Decline for Predicting Survival in ALS"
-
Dr. Seyam has nothing to disclose.
-
Dr. Hubbell has nothing to disclose.
-
Diantha Howard has nothing to disclose.
-
Ms. Skelly has nothing to disclose.
-
Dr. Waheed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.
-
Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Apellis. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Tandan has received research support from Alexion. The institution of Dr. Tandan has received research support from Apellis. The institution of Dr. Tandan has received research support from Cytokinetics.